Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
Primary Purpose
Infertility Associated With Endometriosis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Goserelin Acetate
Sponsored by
About this trial
This is an interventional treatment trial for Infertility Associated With Endometriosis focused on measuring GnRH-a, endometriosis, efficiency
Eligibility Criteria
Inclusion Criteria:
- Infertile patients
- Endometriosis I-II phase:according to Revised American Society for Reproductive Medicine classification of endometriosis: 1996
- BMI:19-28 kg/㎡
- Ovarian reserve function is normal(M2-5:bilateral antral follicles≥6 FSH:5-12U/ml)
Exclusion Criteria:
- Male factor causes infertility
- hydrosalpinx or salpingemphraxis
- Uterine malformation
- Uterine cavity lesion
- Contra-indications for GnRH-a
- not willing to participate
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
GnRH-a
non GnRH-a
Arm Description
patients treated with GnRH-a after surgery and Outpatient guidance .
patients treated with outpatient guidance only.
Outcomes
Primary Outcome Measures
Cumulative pregnancy rate
Cumulative pregnancy rate of 18 month after surgery
Time interval between surgery and natural pregnancy
Time interval between surgery and natural pregnancy
miscarriage rate
miscarriage rate of patients who get natural pregnancy
Secondary Outcome Measures
Full Information
NCT ID
NCT02779387
First Posted
May 18, 2016
Last Updated
May 19, 2016
Sponsor
Peking University People's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02779387
Brief Title
Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
Official Title
Efficacy of Laparoscopic Surgery Combined With GnRH-a in the Treatment of Endometriosis Associated Infertility: A Multicenter, Prospective, Randomized-control-trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2016
Overall Recruitment Status
Unknown status
Study Start Date
May 2016 (undefined)
Primary Completion Date
May 2020 (Anticipated)
Study Completion Date
May 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Peking University People's Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is a multicenter, randomized-control-trial. This study select 1184 Infertile patients associated with endometriosis diagnosed by laparoscopy surgery. Patients are going to be divided into two groups according to 1:1 ratio randomly assigned to receive GnRH-a. Cumulative pregnancy rate, end of treatment to natural pregnancy time, accept the assisted reproductive treatment rate, miscarriage rate, live birth rate will be recorded.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility Associated With Endometriosis
Keywords
GnRH-a, endometriosis, efficiency
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1184 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
GnRH-a
Arm Type
Experimental
Arm Description
patients treated with GnRH-a after surgery and Outpatient guidance
.
Arm Title
non GnRH-a
Arm Type
No Intervention
Arm Description
patients treated with outpatient guidance only.
Intervention Type
Drug
Intervention Name(s)
Goserelin Acetate
Primary Outcome Measure Information:
Title
Cumulative pregnancy rate
Description
Cumulative pregnancy rate of 18 month after surgery
Time Frame
18 month after surgery
Title
Time interval between surgery and natural pregnancy
Description
Time interval between surgery and natural pregnancy
Time Frame
18 month after surgery
Title
miscarriage rate
Description
miscarriage rate of patients who get natural pregnancy
Time Frame
18 month after surgery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infertile patients
Endometriosis I-II phase:according to Revised American Society for Reproductive Medicine classification of endometriosis: 1996
BMI:19-28 kg/㎡
Ovarian reserve function is normal(M2-5:bilateral antral follicles≥6 FSH:5-12U/ml)
Exclusion Criteria:
Male factor causes infertility
hydrosalpinx or salpingemphraxis
Uterine malformation
Uterine cavity lesion
Contra-indications for GnRH-a
not willing to participate
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Willing to share IPD
Learn more about this trial
Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
We'll reach out to this number within 24 hrs